Gyre Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
-25.06
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-0.3

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-40.84-14.08-6.72-34.22-44.15-23.18-32.68-4.75265.00-16.85N/A-33.67
Price/Sales ratio
4.84K118.82285.45724.97221.19KN/A86.6556.99768.3213.80N/A110.59K
Price/Book Value ratio
12.216.617.0823.9811.0617.9423.8610.17-28.12-98.94N/A14.50
Price/Cash Flow ratio
-38.64-10.87-6.16-37.01-46.48-28.11-32.97-4.99-18.4360.48N/A-37.29
Price/Free Cash Flow ratio
-38.64-10.72-6.01-36.96-45.87-28.07-32.81-4.94-16.0190.49N/A-36.97
Price/Earnings Growth ratio
1.340.270.110.480.76-0.350.954.59-2.610.00N/A0.20
Dividend Yield
N/AN/AN/A0.53%N/AN/AN/AN/A7.38%N/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-1815.27%-240.45%-2545.36%-1161.98%-357800%N/A56.25%-0.57%-0.50%95.91%N/A-178900%
Operating Profit Margin
-10805.09%-788.68%-5117.29%-2143.61%-563700%N/A-273.86%-1197.79%-1084.50%-59.25%N/A-281850%
Pretax Profit Margin
-10596%-843.54%-4246.86%-2117.97%-500916.66%N/A-268.47%-1198.32%-994.20%-67.84%N/A-250458.33%
Net Profit Margin
-11862.90%-843.54%-4246.86%-2117.97%-500916.66%N/A-265.14%-1198.32%289.92%-81.91%N/A-250458.33%
Effective Tax Rate
-11.95%-3.50%-18.20%0.80%-12.53%4.15%1.24%0.04%-4.40%-11.06%N/A-4.19%
Return on Assets
-29.12%-21.23%-44.48%-54.56%-24.05%-53.66%-58.55%-157.97%8.09%-79.74%N/A-38.86%
Return On Equity
-29.90%-46.97%-105.43%-70.06%-25.05%-77.39%-73.01%-214.00%-10.61%587.14%N/A-51.22%
Return on Capital Employed
-27.23%-43.45%-126.62%-70.91%-28.15%-82.22%-74.45%-211.80%-74.10%-69.67%N/A-55.19%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
37.110.920.823.8625.823.325.023.231.312.64N/A14.57
Cash ratio
19.360.770.461.656.500.531.703.131.281.67N/A3.51
Days of Sales Outstanding
187.14102.6128.358.60N/AN/A57.7290.427.87K54.17N/AN/A
Days of Inventory outstanding
N/A2.07K673.21150.83N/AN/A0.03282.872.80K337.05N/AN/A
Operating Cycle
187.142.17K701.57159.44N/AN/A57.76373.3010.67K391.22N/AN/A
Days of Payables Outstanding
28.0657.5228.9421.2221.2135.61236.25317.4755.8027.94N/A28.41
Cash Conversion Cycle
159.072.11K672.63138.21-21.21N/A-178.4955.8310.62K363.27N/A-10.60
Debt Ratios
Debt Ratio
N/A0.480.500.12N/A0.010.010.03N/AN/AN/A0.00
Debt Equity Ratio
N/A1.071.200.16N/A0.020.020.04N/AN/AN/A0.01
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.010.01N/AN/AN/AN/A0.00
Total Debt to Capitalization
N/A0.510.540.14N/A0.020.020.04N/AN/AN/A0.01
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/A-0.56-0.95-3.92N/A-24.20-33.48-42.36N/AN/AN/A-12.10
Company Equity Multiplier
1.022.212.371.281.041.441.241.35-1.31-7.36N/A1.24
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-125.39-10.92-46.29-19.58-4.75KN/A-2.62-11.41-41.680.22N/A-2.37K
Free Cash Flow / Operating Cash Flow Ratio
1.001.011.021.001.011.001.001.011.150.66N/A1.00
Cash Flow Coverage Ratio
N/A-0.56-0.95-3.92N/A-24.20-33.48-42.36N/AN/AN/A-12.10
Short Term Coverage Ratio
N/A-0.56-0.95-3.92N/A-90.29-83.02-42.36N/AN/AN/A-45.14
Dividend Payout Ratio
N/AN/AN/A-18.32%N/AN/AN/AN/A1956.16%N/AN/AN/A